Cancer diagnosis using label-free SERS-based exosome analysis

Area of Science:

• Biomedical Engineering
• Analytical Chemistry
• Oncology

Background:

• Exosomes are promising liquid biopsy biomarkers for cancer diagnosis due to their origin-specific biomolecules.
• Low exosome concentrations in body fluids hinder clinical translation for cancer detection.
• Surface-Enhanced Raman Spectroscopy (SERS) provides a sensitive, label-free approach for analyzing exosomes.

Purpose of the Study:

• To review label-free Surface-Enhanced Raman Spectroscopy (SERS) techniques for exosome detection.
• To explore advancements in SERS substrates and machine learning for exosome analysis.
• To discuss challenges and future prospects of SERS-based exosome analysis in cancer diagnosis.

Main Methods:

• Review of exosome isolation and characterization techniques relevant to SERS analysis.
• Analysis of recent developments in Surface-Enhanced Raman Spectroscopy (SERS) substrates.
• Exploration of machine learning algorithms for SERS-based exosome fingerprint analysis.

Main Results:

• Label-free SERS demonstrates high sensitivity and specificity for exosome detection.
• Advancements in SERS substrates enhance signal amplification and detection limits.
• Machine learning effectively analyzes complex SERS spectral data for exosome identification.

Conclusions:

• SERS is a powerful tool for label-free exosome detection, overcoming limitations of low concentrations.
• Optimized SERS substrates and machine learning integration are key to clinical translation.
• SERS-based exosome analysis holds significant potential for improving early cancer diagnosis and monitoring.